Strategic Thinking in Test Selection for Mass SARS-CoV-2 Testing
J Appl Lab Med
.
2021 Nov 1;6(6):1688-1693.
doi: 10.1093/jalm/jfab078.
Authors
Sejal Morjaria
1
,
Rosa Nouvini
2
,
S Joseph Sirintrapun
3
Affiliations
1
Infectious Disease, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
2
Medical Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
3
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
PMID:
34165509
PMCID:
PMC8344554
DOI:
10.1093/jalm/jfab078
No abstract available
MeSH terms
COVID-19 Nucleic Acid Testing
COVID-19 Testing
COVID-19*
Humans
SARS-CoV-2*